Seer Inc
NASDAQ:SEER

Watchlist Manager
Seer Inc Logo
Seer Inc
NASDAQ:SEER
Watchlist
Price: 1.95 USD 3.72% Market Closed
Market Cap: 108.8m USD

Operating Margin

-544.9%
Current
Improving
by 92.2%
vs 3-y average of -637.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-544.9%
=
Operating Income
$-88.7m
/
Revenue
$16.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-544.9%
=
Operating Income
$-88.7m
/
Revenue
$16.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Seer Inc
NASDAQ:SEER
109.8m USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241B USD
Loading...
US
Danaher Corp
NYSE:DHR
170.9B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
US
Waters Corp
NYSE:WAT
23.7B USD
Loading...

Market Distribution

Lower than 91% of companies in the United States of America
Percentile
9th
Based on 14 112 companies
9th percentile
-544.9%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Seer Inc
Glance View

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 118 full-time employees. The company went IPO on 2020-12-04. The firm enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is comprised of consumables, an automation instrument and software. Its Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company’s Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its SP100 automation instrument. Its SP100 automation instrument is custom-configured liquid handling workstation. The firm's Proteograph Instrument Control Software (PICS) for the SP100 instrument is fixed and designed to its specified workflow.

SEER Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-544.9%
=
Operating Income
$-88.7m
/
Revenue
$16.3m
What is Seer Inc's current Operating Margin?

The current Operating Margin for Seer Inc is -544.9%, which is above its 3-year median of -637.1%.

How has Operating Margin changed over time?

Over the last 3 years, Seer Inc’s Operating Margin has increased from -703.3% to -544.9%. During this period, it reached a low of -706.4% on Dec 31, 2024 and a high of -544.9% on Jul 30, 2025.

Back to Top